Single-Nucleus RNA Sequencing (snRNA-seq) Services
Single-nucleus RNA sequencing (snRNA-seq) is a transcriptomic method that profiles gene expression from individual nuclei rather than whole cells, making it particularly suited for frozen, archived, and difficult-to-dissociate tissues. By extracting and sequencing RNA from intact nuclei, snRNA-seq bypasses the need for fresh, viable cell suspensions—enabling transcriptomic analysis of clinical archives, biobank specimens, and previously inaccessible sample types.
- Profiling of frozen, OCT-embedded, and long-term archived tissues
- Reduced bias against large, fragile, or hard-to-dissociate cell types
- Data compatible with scRNA-seq reference datasets for comparative analysis
- Compatible with downstream integration into spatial transcriptomics workflows
What Is snRNA-seq and Why Use It for Frozen Tissues?
Standard single-cell RNA sequencing (scRNA-seq) requires fresh tissue samples that can be enzymatically dissociated into viable single-cell suspensions. This requirement excludes most clinical archives, biobank specimens, and tissues collected under non-optimal conditions—which represent a large proportion of available human and preclinical research material.
snRNA-seq addresses this gap by isolating nuclei directly from frozen tissue through mechanical disruption and density-based purification, followed by droplet-based capture on the 10x Genomics Chromium platform. Because nuclei are more robust than intact cells and less affected by freeze-thaw cycles, the method works reliably on samples stored at −80 °C for extended periods.
Recent methodological work has demonstrated successful snRNA-seq from long-term frozen brain tumor tissues, with nuclei yield and data quality comparable to freshly processed specimens (Nature Scientific Reports, 2025). The approach has been validated across brain, tumor, kidney, heart, adipose, and muscle tissues, suggesting broad applicability for retrospective cohort studies and translational research.
snRNA-seq vs scRNA-seq: Key Differences for Archived Samples
Choosing between snRNA-seq and scRNA-seq depends on sample availability, tissue type, and research question. The table below summarizes the main differences to guide your decision.
| Dimension | snRNA-seq | scRNA-seq |
|---|---|---|
| Sample type compatibility | Frozen, archived, OCT-embedded tissues | Fresh, viable tissue only |
| Cell-type representation | Captures fragile, large, and hard-to-dissociate cells | Biased toward easily dissociated cells |
| Transcript source | Nuclear RNA (including intronic sequences) | Whole-cell RNA (including cytoplasmic transcripts) |
| Dissociation-induced artifacts | Minimal—mechanical isolation only | Enzyme-induced transcriptional stress |
| Data integration | Compatible with scRNA-seq references via standard pipelines | Used as reference standard |
For projects involving frozen cohorts, biobank archives, or delicate tissues such as brain, adipose, or cardiac muscle, snRNA-seq is the practical path to single-cell-resolution transcriptomic data. For fresh tissue where whole-cell transcript coverage is required, scRNA-seq remains the appropriate choice.
Our snRNA-seq Workflow: From Frozen Tissue to Data
The workflow follows a coordinated pipeline from sample receipt through data delivery, with QC checks at each stage.
- Sample receipt and QC
Frozen tissue is logged, inspected for physical integrity, and processed under cold conditions. Tissue weight and morphology are recorded. Samples that fail initial QC criteria are flagged before processing begins.
- Nuclei isolation
Tissue is mechanically homogenized in cold lysis buffer. The homogenate is filtered, washed, and purified to obtain a clean nuclear suspension. QC checkpoint: Nuclear yield, purity, and integrity are evaluated by DAPI staining and brightfield microscopy before proceeding.
- Droplet-based capture and library construction
Purified nuclei are loaded onto the 10x Genomics Chromium platform for GEM formation. Reverse transcription, cDNA amplification, and library construction follow standard snRNA-seq protocols. QC checkpoint: cDNA yield and fragment size distribution are assessed.
- Sequencing
Libraries are sequenced on an Illumina platform at a depth appropriate for the experimental design. Sequencing metrics including Q30 score, mapping rate, and saturation are monitored.
- Data processing and delivery
Raw FASTQ files are processed through a standardized pipeline: alignment, barcode counting, Molecular barcode deduplication, and generation of a gene-barcode expression matrix. Deliverables include the expression matrix, QC report, and downstream analysis results.
Sample Requirements and Quality Control
The table below lists general sample submission guidelines. Specific requirements may vary by tissue type and project scope.
| Parameter | Guideline |
|---|---|
| Sample type | Frozen tissue (snap-frozen, OCT-embedded), cryopreserved cell pellets |
| Recommended input | ~50–100 mg tissue (weight-dependent on tissue type and cell density) |
| Storage and shipping | −80 °C storage; ship on dry ice in sealed cryogenic vials or bags |
| QC checkpoints | Tissue physical integrity → nuclei yield and purity post-isolation → cDNA quality → library fragment profile |
| Notes | Contact our team for tissue-type-specific handling instructions. Samples not meeting initial QC criteria will be discussed before proceeding. |
Representative Data Outputs
Data from snRNA-seq projects enables cell-type identification, differential expression, and spatial mapping when combined with spatial transcriptomics data. The visual outputs below illustrate the types of results routinely generated.
UMAP clustering and cell-type annotation
After quality filtering and normalization, nuclei are clustered and visualized in two-dimensional UMAP space. Clusters are annotated based on canonical marker gene expression. This step reveals the major cell populations present in the tissue—for example, distinguishing neurons, astrocytes, microglia, and oligodendrocytes in brain tissue—without requiring prior knowledge of sample composition.
Marker gene identification
Differentially expressed genes between clusters are identified and visualized as heatmaps, violin plots, or dot plots. These data support biological interpretation of each cell population and can be compared against published reference datasets.
Comparative data integration
snRNA-seq data can be integrated with scRNA-seq reference datasets from the same tissue type, using anchor-based or mutual nearest neighbor algorithms. This enables direct comparison of cell-type composition and gene expression across fresh and frozen sample cohorts.
Spatial transcriptomics deconvolution
When snRNA-seq data is combined with spatial transcriptomics data from adjacent or matched sections, cell-type proportions are estimated for each spatial spot. This joint analysis places cell identities in their native tissue context.
Representative figures shown are based on published protocol benchmarks and are for illustration purposes. Actual project results vary by sample type, tissue quality, and experimental design.
Bioinformatics Analysis and Deliverables
Our bioinformatics analysis is designed to provide interpretable results while maintaining flexibility for advanced study-specific needs.
Standard analysis deliverables
- Raw sequencing data (FASTQ)
- Filtered gene-barcode expression matrix
- QC summary report (nuclei count, Molecular barcode per nucleus, gene detection rate, mitochondrial fraction)
- Cell clustering and UMAP visualization with cell-type annotation
- Differential gene expression analysis between clusters or experimental groups
- GO and KEGG pathway enrichment analysis
Optional advanced analysis
- RNA velocity and developmental trajectory inference
- Cell-cell communication analysis (CellChat, NicheNet, or equivalent)
- Integration with external scRNA-seq reference datasets
- Integration with spatial transcriptomics data for tissue-level cell-type mapping
- Custom analysis designed around specific study objectives
Analysis scope and deliverables are agreed upon during project planning to match the study design, sample size, and research questions.
Why Choose snRNA-seq for Frozen and Archived Tissue Research?
snRNA-seq is a practical choice when your samples do not meet the viability requirements of scRNA-seq, or when you need to profile cell types that are lost during enzymatic dissociation. It suits the following research scenarios:
Retrospective cohort analysis
You have a collection of frozen biopsies or surgical specimens stored in a biobank and want to profile them at single-cell resolution. snRNA-seq enables transcriptomic analysis of these valuable archived materials without requiring fresh tissue collection.
Brain and neuroscience research
Neural tissue is difficult to dissociate into viable single cells, and frozen post-mortem brain tissue is frequently the only available material. snRNA-seq has been widely adopted in neuroscience for profiling neuronal and glial populations from frozen brain specimens.
Tumor microenvironment studies
Frozen tumor archives allow comparison across treatment groups, time points, or molecular subtypes that cannot be prospectively collected. snRNA-seq reveals the cellular composition and transcriptional state of tumor and immune cells within archived biopsy specimens.
Multi-omics integration projects
snRNA-seq data pairs naturally with spatial omics solutions, allowing cell-type deconvolution on the same tissue block or adjacent sections. This integrated approach adds spatial context to single-cell-resolution gene expression data.
The method captures intronic RNA sequences, which can improve cell-type discrimination for certain populations and provide information on RNA processing that whole-cell sequencing may underrepresent.
Case Studies: snRNA-seq in Frozen Brain Tumor Tissues
Source: A simplified preparation method for single-nucleus RNA-sequencing using long-term frozen brain tumor tissues. Nature Scientific Reports, 2025.
Background: Long-term frozen brain tumor tissues represent a valuable but challenging resource for transcriptomic profiling. Standard scRNA-seq requires fresh viable tissue, excluding most archived biobank specimens from single-cell-resolution analysis. This study aimed to develop and validate a simplified snRNA-seq preparation method specifically for long-term frozen pediatric glioma tissues, addressing a critical gap in retrospective translational research.
Methods: Intact nuclei were isolated from archived frozen pediatric glioma samples that had been stored for extended periods, using mechanical homogenization and density-based purification. Multiple snRNA-seq systems (including 10x Genomics Chromium and alternative platforms) were compared for nuclei yield, capture efficiency, transcript detection rates, and data reproducibility. The simplified protocol reduced processing steps while maintaining nuclei integrity and RNA quality suitable for downstream sequencing.
Results: The study confirmed that frozen brain tumor tissues stored long-term can yield high-quality snRNA-seq data comparable to freshly processed specimens. Cell-type identification, tumor heterogeneity analysis, and differential gene expression profiling were successfully performed from archived samples. The simplified protocol reduced hands-on processing time without compromising data quality, demonstrating a practical path for utilizing biobank archives in single-cell-resolution transcriptomic studies.
Conclusion: This study validates that simplified snRNA-seq preparation from long-term frozen brain tumor tissues is a feasible and reproducible approach for retrospective single-cell transcriptomic analysis. The method expands the utility of archived biobank specimens—previously considered unsuitable for single-cell analysis—enabling large-scale retrospective cohort studies and translational research applications without the need for fresh tissue collection.
Integration with Our Spatial Multi-Omics Platform
snRNA-seq is one component of our broader spatial multi-omics service portfolio. Data generated from snRNA-seq can be directly integrated with spatial transcriptomics data from matched tissue sections, providing complementary layers of information.
snRNA-seq + spatial transcriptomics
- Use snRNA-seq to define cell-type signatures and spatial transcriptomics to map their tissue distribution. This dual-layer approach reveals how cellular composition varies across anatomical regions, lesion zones, or treatment margins.
snRNA-seq + spatial genomics
- Combine transcriptomic cell typing with genomic profiling from adjacent sections for a multi-modal view of clonal architecture and transcriptional output.
snRNA-seq + spatial proteomics
- Cross-reference RNA-level cell types with protein-level spatial readouts when both assays are performed on the same tissue block.
By aligning these layers within one platform, you obtain coordinated molecular and spatial context, reducing time spent on cross-vendor data wrangling. For related options, see our spatial transcriptomics services and spatial genomics service pages.
Frequently Asked Questions
References
- A simplified preparation method for single-nucleus RNA-sequencing using long-term frozen brain tumor tissues. Nature Scientific Reports, 2025.
- snPATHO-seq, a versatile FFPE single-nucleus RNA sequencing method. Nature Communications, 2024.
- Optimized nucleus isolation protocol from frozen mouse tissues for single-nucleus RNA sequencing. Frontiers in Cell and Developmental Biology, 2023.
- Comparative analysis of nuclei isolation methods for brain single-nucleus RNA sequencing. Cell Reports Methods, 2026.
- Demonstrated Protocol: Nuclei Isolation and Cleanup from Frozen Tissue. S2 Genomics, 2024.
